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AbstrACt
Introduction South Asia is home to more than 
300 million smokeless tobacco (ST) users. Bangladesh, 
India and Pakistan as signatories to the Framework 
Convention for Tobacco Control (FCTC) have developed 
policies aimed at curbing the use of tobacco. The 
objective of this study is to assess the compliance of ST 
point- of- sale (POS) vendors and the supply chain with 
the articles of the FCTC and specifically with national 
tobacco control laws. We also aim to assess disparities 
in compliance with tobacco control laws between ST and 
smoked tobacco products.
Methods and analysis The study will be carried out 
at two sites each in Bangladesh, India and Pakistan. We 
will conduct a sequential mixed- methods study with five 
components: (1) mapping of ST POS, (2) analyses of ST 
samples packaging, (3) observation, (4) survey interviews 
of POS and (5) in- depth interviews with wholesale dealers/
suppliers/manufacturers of ST. We aim to conduct at least 
300 POS survey interviews and observations, and 6–10 
in- depth interviews in each of the three countries. Data 
collection will be done by trained data collectors. The 
main statistical analysis will report the frequencies and 
proportions of shops that comply with the FCTC and local 
tobacco control policies, and provide a 95% CI of these 
estimates. The qualitative in- depth interview data will be 
analysed using the framework approach. The findings will 
be connected, each component informing the focus and/or 
design of the next component.
Ethics and dissemination Ethical approvals for the study 
have been received from the Health Sciences Research 
Governance Committee at the University of York, UK. In- 
country approvals were taken from the National Bioethics 
Committee in Pakistan, the Bangladesh Medical Research 
Council and the Indian Medical Research Council. Our 
results will be disseminated via scientific conferences, 
peer- reviewed research publications and press releases.
IntroduCtIon
Smokeless tobacco (ST) refers to all tobacco 
products that are used without burning 
the product.1 The International Agency 
for Research on Cancer estimates that ST 
contains more than 30 carcinogens.2 The use 
of ST is associated with an increased incidence 
of head, neck and gastrointestinal cancers.3–5 
Additionally, ST use is associated with oral 
potentially malignant disorders6 and a variety 
of other oral and systemic diseases.7 8An 
estimated 300 million people around the 
globe use ST products in some form, and 
the majority (≥85%) of these ST users live 
strengths and limitations of this study
 ► This will be the first multicountry study on the 
smokeless tobacco (ST) supply chain in South Asia 
that aims to map ST points of sale using geographi-
cal information systems.
 ► Building on the methods used by the global “Tobacco 
Packs Surveillance System” project, our proposed 
study will develop/update the inventory of ST prod-
ucts available in Bangladesh, India and Pakistan.
 ► Purposive sampling of our main study sites may 
decrease the external validity of our methods and 
results.
 ► Owing to a fear of the relevant authorities, the an-
swers to our survey questions on taxes and finances 
might not be completely accurate.
 ► We will not be able to do a regression analysis, in-
cluding shop characteristics, for the pack analysis 
component, as we are only collecting unique packs 
and not all packs from each shop.
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in South Asia.1 9 The use of ST products is particularly 
common in India, Bangladesh and Pakistan, where it is 
considered an acceptable social norm.10 This situation is 
further complicated by the presence of high amounts of 
tobacco- specific nitrosamines, the main cancer- causing 
agents in tobacco, in the products available in South Asia, 
compared with the rest of the world.11
The Framework Convention for Tobacco Control 
(FCTC) is a global treaty that aims to enhance tobacco 
control measures and incorporate the provisions of the 
framework into their national tobacco control laws.12Al-
though the FCTC is aimed at curbing all types of tobacco 
use, the focus of tobacco control in most countries has 
been on controlling smoking, with control of the non- 
smoking forms of tobacco often neglected.13 14 The 2016 
Global Progress Report on the implementation of FCTC 
highlighted gaps in the formulation and implementa-
tion of ST control policies in most parties to the FCTC.15 
Bangladesh, India and Pakistan are signatories to the 
FCTC and have made variable progress in implementing 
the articles of the framework by developing national 
tobacco control policies.16
The tightening up of smoking regulations has been 
associated with a reported shift from smoking to ST use 
in some South Asian countries.9 17 The increase in ST use 
can be attributed to a variety of factors, including, but 
not limited to, cultural acceptance, perceived safety of ST 
products compared with smoking, harm reduction, low 
prices and lax or absent ST control laws.14
A 2018 report from the Global Knowledge Hub on 
Smokeless Tobacco indicated progress being made with 
regards to ST control policies and regulations in South 
Asia.14 Many of these regulations and laws are aimed 
at demand reduction via various interventions at the 
tobacco points of sale (POS), for example, removal of 
tobacco products’ displays, and restrictions and bans on 
the advertisement of tobacco products at the POS.18 19 
The success of these regulations and laws in curbing the 
tobacco epidemic in South Asia largely depends on the 
degree of compliance with the implementation of these 
laws and regulations.20 However, the evidence on the 
implementation of the ST control laws and regulations at 
the POS in the context of India, Bangladesh and Pakistan 
is scarce. Most of the previous work carried out in these 
countries focused on tobacco advertisement and promo-
tion at the POS and health warnings on ST packaging,21–26 
with little emphasis on the other provisions of the FCTC, 
such as sale to/by minors, price and taxation, and provi-
sion of viable alternatives. As such, there is a need for a 
comprehensive assessment of the compliance of POS in 
India, Pakistan and Bangladesh with the local ST control 
policies and the specific articles of the FCTC.
This multicountry sequential mixed- methods study aims 
to provide a comprehensive assessment of compliance of 
ST POS and products with the tobacco control laws in our 
three target countries. Furthermore, we aim to elicit infor-
mation on any disparities between the implementation of 
FCTC/local laws for ST and smoking. We will also develop 
a country- specific inventory of tobacco products, to gain 
insight into the diversity of the products available in the 
local market, as well as identifying illicit products. Addition-
ally, we will assess the barriers and facilitators to compliance 
of the ST wholesale dealers and suppliers with the different 
provisions of the FCTC/local laws.
MEthods And AnAlysIs
study design
We will conduct a sequential mixed- methods study, incorpo-
rating quantitative work (geomapping of ST POS, in- house 
analyses of ST products, POS survey interviews and observa-
tions) and qualitative work (in- depth- interviews with supply 
chain actors, eg, wholesale dealers and suppliers). The 
findings from each component will be connected and used 
to inform the focus and/or the design of the next compo-
nent, that is, mapping of the POS will allow us to build a 
sampling frame from which we will randomly choose survey 
interview respondents. The ST pack analyses will provide us 
an insight into manufacturing and sale practices that can 
be incorporated into the POS survey interview tool and the 
topic guide for in- depth interviews. The findings from the 
survey interviews and observations of the POS will guide 
the development of country- specific topic guides for the 
in- depth interviews.
study sites
We will conduct this study in Bangladesh, India and Paki-
stan. In each country, we have purposively selected two sites 
based on the use and diversity of the available ST products. 
In India, the study will be conducted in the North- East and 
North- West districts of Delhi. In Bangladesh, the study will 
be conducted in the districts of Dhaka and Rangpur. In Paki-
stan, the study will be conducted in the districts of Karachi 
and Peshawar. In Pakistan and Bangladesh, the selected 
sites are the hubs of ST use and manufacture; for India, our 
rationale for choosing the sites was based on Delhi being a 
metropolitan city with a diverse population and products 
and also the logistics available to study team.
study duration
The data collection will be carried out from 1 June 2019 
to 31 December 2020, and analyses will be completed by 
30 March 2021.
General sampling strategy
We will use a multistage mixed sampling technique for 
the study (figure 1).
Stage 1
Within each of the selected administrative areas (district/
division), we will purposively select one predominantly 
urban and one predominantly rural subdistrict. Our study 
sites included districts/areas, which comprise urban, peri- 
urban and rural areas. We will use the available local govern-
ment documents, latest census and expert opinion of local 
researchers to identify two subdistricts/areas at each site, 
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Figure 1 General sampling strategy to be used at all sites. (a) Within each of the selected administrative areas (district/
division), we will purposively select one predominantly urban and one predominantly rural subdistrict. We will use the available 
local government documents, latest census and expert opinion of local researchers to identify two subdistricts/areas at 
each site, one predominantly urban and the other predominantly rural/peri- urban. (b) We will randomly select three smaller 
administrative units per subdistrict. These will be our primary sampling units (PSU). (c) From each PSU, we will randomly select 
two enumeration blocks/neighbourhood areas/villages; these will be our secondary sampling units (SSU). (d) From each SSU, 
we will recruit up to 13 points of sale (POS). (e) Required sample size/country is 290; through this strategy, we will be able to 
recruit up to 312 POS.
one predominantly urban and the other predominantly 
rural/peri- urban.
Stage 2
We will randomly select three smaller administrative units 
per subdistrict. These will be our primary sampling units 
(PSU).
Stage 3
From each PSU, we will randomly select two enumeration 
blocks/neighbourhood areas/villages; these will be our 
secondary sampling units (SSU).
data collection (general considerations)
At each study site, we will deploy a team of trained data 
collectors to administer the quantitative data collection 
instruments (comprising the geomapping, in- house anal-
ysis of the ST products packaging, structured POS vendor 
survey interview and observation components). Data 
collectors will be trained on how to administer the various 
study tools beforehand. They will also receive training in 
obtaining informed and written/verbal consent. Calibra-
tion for the product in- house analysis component will be 
done via video conferencing involving study teams from all 
sites. A qualitative research specialist will train one person 
at each participating site to conduct and transcribe the 
in- depth interviews with the suppliers and/or manufac-
turers. The data will be monitored for quality and complete-
ness by the site leads/study leads/principal investigator. We 
will also conduct small pilot studies in each country to field- 
test our study tools.
data management
The data will be initially collected on a paper- based ques-
tionnaire and then transferred to a central database kept on 
a secure server at the University of York. Each ST product, 
POS vendor, supplier and manufacturer recruited in the 
study will be allotted a unique identification number and 
the recorded data will not contain any identifiable infor-
mation about them. Only the study leads/principal investi-
gator/study statistician will have access to the database and 
data collection tools. All filled questionnaires will be stored 
in locked filing cabinets at the collaborating institutions in 
each of the study centres.
In line with the General Data Protection Regulations of 
the European Union and the Research Governance Frame-
work for Health and Social Care Research, the data will be 
securely archived by the University of York for a minimum 
of 5 years after the completion of the study. Following 
authorisation from the sponsor, arrangements for confi-
dential destruction will then be made. Recordings from the 
in- depth interviews will be deleted at the end of the study. If 
an individual withdraws consent for their data to be used, it 
will be destroyed without breach of confidentiality.
study-CoMponEnt-spECIfIC MEthods
pos geomapping
Eligibility criteria for POS
A POS will be eligible for inclusion in the study if it sells 
any form of ST. The common types of tobacco POS that 
might be eligible for our study are:
1. General/departmental stores.
copyright.
 o
n
 June 18, 2020 at Pakistan:BM
J-PG
 Sponsored. Protected by
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-036468 on 17 June 2020. Downloaded from 
4 Khan Z, et al. BMJ Open 2020;10:e036468. doi:10.1136/bmjopen-2019-036468
Open access 
2. Petrol pump/gas station stores.
3. Beer or liquor stores.
4. Paan (betel quid) shops.
5. Grocery stores
6. Exclusive tobacco shops.
7. Discount shops.
8. Mobile vendors/carts.
9. Stationary carts.
10. Country- specific additional POS types.
Identifying and mapping eligible POS
To identify the eligible POS, we will employ standard 
approaches for tobacco POS audits.27 This will entail:
1. Developing a list of tobacco sellers in the selected areas 
by collecting the details of local vendors, who have a 
license to sell tobacco products (if applicable), and/or 
the acquisition of general lists of local businesses/sell-
ers from trade unions and/or local administrative au-
thorities and combining potential tobacco POS from 
these lists.
2. This will be followed by ‘ground truthing’ by trained 
data collectors, who will visit these shops to ascertain 
(a) the existence of the POS and (b) the sale of ST 
products at these POS.
3. Once ascertained, each eligible POS will be allotted 
a unique identification number and its location will 
be recorded via the Google Maps digital application. 
The application gives its users their current location 
on Google Maps, the Global Positioning System (GPS) 
coordinates and the geolocation status.
4. If no prior lists (license holders or businesses/sellers) 
are available at the study location(s), our data collec-
tion team will do ‘canvassing’ of the ST POS by walking 
along all the primary and secondary roads in that area 
and identifying eligible ST POS (online supplementa-
ry appendix 1).
5. Additionally, we will request each ascertained POS ven-
dor to identify other ST POS, which will be added to 
the list.
6. If data collectors observe a mobile vendor during the 
ground truthing or canvassing at the study sites, the 
area where the team establishes the first contact with 
that vendor will be marked as his/her location.
Measuring the density of ST POS
We will collect the most recent official population census 
data of our selected study sites from the relevant depart-
ment(s) in each country. If such data are not available, 
we will use unofficial estimates gathered from the local 
administration. The density of the POS will be calculated 
per 1000 population at our study sites.
Measuring the distance of the POS from schools
We will acquire the list of all schools along with their GPS 
coordinates, situated in the selected SSU from the local 
education departments. If the data are not available, our 
team will visit each school physically, drop a Google Maps 
pin at the school gate and record the coordinates. We will 
plot all the ST POS and the schools on a digital map to 
assess if there is compliance with the local laws that ban 
the sale of tobacco products in the vicinity (distance will 
vary according to country) of the schools.
st products in-house analysis
Eligibility criteria
All brands of ST products available in the markets at the 
study sites will be procured. For a product to be eligible, it 
must contain tobacco. The collection of the ST products will 
be based on the brand names and not the generic product, 
for example, all brands of Gutkha available in the local 
market will be collected. Loose products that are not sold 
in packaging will be eligible, but only one generic sample 
of the product will be procured. The most commonly sold 
brand/make of cigarettes, cigars, cigarillos and beedi, 
according to the selected vendor, will be procured.
Sample collection and storage
All ST sale shops/vendors identified in the selected SSU 
by the geomapping exercise will be approached to procure 
the ST products that are available in the local markets. We 
will employ an adapted form of the unique packs sampling 
technique used for the “Tobacco Packs Surveillance System 
(TPackSS)” samples collection.28 One of every unique pack 
of ST (any pack with at least one difference in an exterior 
feature of the pack including size, brand name, presenta-
tion, colours, cellophane, packaging material (ie, hard or 
soft tin) and the inclusion of a promotional item) available 
in the store will be purchased. This sampling will begin at 
a randomly selected eligible vendor. After the purchase at 
the initial vendor, at each of the remaining eligible vendors, 
one of every ST pack that was not already purchased 
at a previous outlet will be purchased. If the selected 
vendor does not have any new packs (packs that were not 
purchased at another outlet), the sample collection team 
will move onto the next eligible vendor. The sample collec-
tion will continue until the team has approached the last 
eligible vendor. The sample collection team will ascertain 
the retail price of each procured pack from the vendor. 
They will also ascertain if the prices are inclusive of tax or 
not. The sample collection team will neither request nor 
accept a reduced price, in case the vendor offers a discount 
due to the large quantity being purchased, other than in 
those cases where discounted products are already being 
offered to all customers as a part of a promotion. All such 
general promotions, and individual ‘reduced price’ offers, 
will be recorded on a field notes sheet provided to each 
data collector.
Product analyses
All the procured samples will be sorted by product type, 
and each sample will be allotted a unique identification 
number marked on the Ziploc bag with indelible ink. The 
study team at each participating institution will analyse one 
sample at a time, carefully locking it back in the bag before 
moving onto the next sample. A physical inventory of all the 
products will be developed at each site and the data related 
to the products, for example, unique identification number, 
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product family, purchase price and date of purchase, will 
be fed into a digital inventory form (online supplemen-
tary appendix 2) adapted from the TPackSS inventory data 
entry form.
The in- house assessment of the ST products will involve 
assessment and recording of their size, price, tax disclosure, 
ingredient lists, health warnings, manufacturer details, etc. 
Our study tool (online supplementary appendix 3) has been 
adapted from the Tobacco Advertisement and Promotion 
Surveys (TAPS) standard tools. We will collect the samples 
by brand names and assess whether disparities exist between 
ST product categories and/or different manufacturers. We 
will also collect data on the country of manufacture and 
analyse if differences in compliance with the relevant laws 
can be explained by differences in the country of manufac-
ture and/or ‘smuggled/illicit’ designation of the product. 
The definition of illicit products for each participating site 
will be developed after consulting local stakeholders. We 
will also analyse the collected cigarette packs, to assess their 
compliance with the local laws/FCTC. This will also help us 
in the identification of any disparity in the local laws for ST 
and those for cigarettes.
pos survey interviews and observation
Sample size
For the POS observation and interviews, we calculated 
sample sizes for the individual countries based on the 
prevalence of non- compliance with specific provisions of 
the local tobacco control laws in the three countries. The 
point estimates were derived from the published literature, 
that is, 20% of shops selling tobacco to minors in Paki-
stan,29 19.4% POS non- compliant with Cigarettes and other 
Tobacco Products Act (COTPA) regulations regarding 
sizing of the advertisements in India30 and 20% POS non- 
compliant with tobacco advertisement and promotion laws 
in Bangladesh.31
Using the formula sample n=[DEFF*Np(1−p)]/[(d2/
Z21-α/2*(N−1)+p*(1−p)], and assuming a 20% prevalence of 
non- compliance, a CI of 95% and an absolute precision of 
7%, the sample size for each country came out to be 251. 
After accounting for a 15% non- response (based on our 
ST supply chain study in Pakistan and Bangladesh),32 the 
sample size was rounded up to 290 per country. All sample 
size calculations were carried out in OpenEpi software.33
Sampling strategy
We will follow the general sampling strategy (figure 1). 
Once a sampling frame of eligible ST POS in each SSU 
has been developed through the geomapping, a random 
sample of the 13 POS vendors will be recruited from each 
SSU.
Recruitment
After providing brief information about the study to the 
person in charge of the POS at the time of the store obser-
vation, we will formally ask them to provide written consent 
to participate in both the POS observation and POS vendor 
interview components of the study. Those who do not agree 
to participate after receiving the study information will not 
be enrolled in the study. The reasons for declining to partic-
ipate in the study will be recorded. Following consent, the 
data collector will proceed to data collection. The consent 
provider, who could be either the POS owner (not land- 
lords), POS manager or sales assistant(s), will be eligible for 
an interview.
Data collection and tools
An adapted version (online supplementary appendix 4) of 
the Standardized Tobacco Assessment for Retail Settings 
tool34 will be used to record the observations about product 
promotion, advertisement, health warnings, etc. We will 
observe both the exterior and interior of the shops to assess 
compliance with FCTC/local laws. The tool consists of 
data fields on health warnings inside and outside the shop, 
product advertisement, promotions, display shelves, dummy 
packs, product placement, products sold as confectioneries 
and cross- promotion. We will also collect similar data for 
cigarettes and other smoking products, for comparison.
Our interview tool (online supplementary appendix 5) 
has been adapted from a survey instrument that has already 
been field- tested in the UK, Bangladesh, Nepal and Paki-
stan.32 The tool will be translated into local languages at 
each study site. In addition to a series of close- ended ques-
tions on ST products regarding their supply, sale, popularity, 
prices, profits and taxes, the tool also includes similar ques-
tions for cigarettes, to allow for comparative analysis. We will 
collect data on mediating/moderating variables that could 
act as barriers/facilitators to the increased implementation 
of the FCTC/local laws. These variables are awareness of 
local tobacco control legislation, standards and obliga-
tions, awareness of adverse health effects of ST, the effect 
of health warnings on sales, market share of ST products, 
overall sales related to the availability of tobacco products 
for non- exclusive vendors, incentives by manufacturers/
suppliers, profit margins, regular inspections, penalties for 
non- compliance and availability of viable alternatives.
Data analysis
The main statistical analysis will report the frequencies and 
proportions of shops that comply with the WHO FCTC and 
local tobacco control policies, as measured by the different 
items on the survey questionnaire, and provide a 95% CI of 
this estimate. We will also provide summaries for the other 
categorical variables using frequencies and percentages 
and for continuous variables, we will provide means and 
SD in addition to a graphical representation. Medians and 
IQRs will also be computed if the data are skewed.
We will use logistic regression to explore the bivariate asso-
ciation of compliance with shop characteristics, such as the 
type of shop, adjusting for the study design. We will further 
expand these regression models to explore the association 
of compliance with multiple explanatory variables adjusting 
for the study design. Where possible, figures related to ST 
sales will be compared with those of cigarette sales, using 
similar approaches to the above. We will consider a p- value 
of less than 0.05 to be statistically significant. A detailed 
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statistical analysis plan will be developed before the main 
analysis, which will include any a priori subgroup analyses 
and strategies for handling missing data. We will use STATA 
V.15 for analysis.
In-depth interviews (supply chain)
Participants, sampling and recruitment
At each of the six study sites, we will identify, and collect 
contact details of, at least five supply chain actors (from 
manufacturers, wholesalers and suppliers) with the help of 
the POS survey respondents. From this list, we will purpo-
sively recruit three to five participants at each site, ensuring 
that the sample includes at least one manufacturer and one 
supplier from each site.
Data collection
A topic guide will be developed for the interviews. The 
contents of the guide will be based on the findings from the 
POS survey. That is, the responses in the survey that warrant 
further exploration will be identified by the study teams in 
each country and the topic guide aimed at eliciting further 
information on the responses will be developed by the qual-
itative research team. We will start with a standard topic 
guide and then tailor it to the findings from the different 
countries.
The interviews will be conducted at locations that are 
easily accessible to participants, and where they are confi-
dent to speak openly, such as their workplaces or the offices 
of ward/union council office bearers or the village chief’s 
house/hujra. Each interview will last 30–60 min. A trained 
researcher will conduct the interviews in the local language. 
All interviews will be audio recorded.
Data analysis
The interviews will be transcribed verbatim, translated into 
English and analysed using the framework approach.35 The 
framework approach is not associated with a particular epis-
temological viewpoint or theoretical approach and, as such, 
is not necessarily concerned with generating social theory. 
The approach can be used in inductive or deductive anal-
ysis or a combination of the two.36 We will be using an induc-
tive approach and develop a framework matrix, informed 
by the study objectives, the interview topics and data from 
preliminary interviews. The data from the three countries 
will be charted into the same matrix; and then reviewed and 
interrogated to compare and contrast views, seek patterns, 
connections and explanations within the data, including 
comparison across the three countries. Excel software will 
aid data handling.
patient and public involvement
The study is supported by stakeholder groups in each partic-
ipating country. The stakeholder groups consist of health 
professionals, policymakers, representatives from general 
society, students and influencers. The stakeholder groups 
meet once every year, and so far have been involved in the 
design of the study tools, refinement of research questions 
and data collection methods. These groups will also be 
involved in the dissemination of findings from the study.
EthICs And dIssEMInAtIon
We will adhere to the fundamental principles of human 
rights as per the Declaration of Helsinki. Ethical approval 
has been obtained from the University of York ‘Health 
Sciences Research Governance Committee’. This work is 
being carried out by the ASTRA Global Health Research 
Group (Addressing Smokeless Tobacco use and building 
Research capacity in south Asia). Each participating South 
Asian institution in ASTRA has obtained ethical approvals 
from their institutional/national ethics bodies (online 
supplementary appendix 6). All potential participants will 
be provided with information regarding the project and 
written/verbal consent will be taken from each participant 
before recruitment. Consent forms will contain personal 
details, including name, date of birth and address.
All information collected during the study will be kept 
strictly confidential. There will be restricted access and 
disposal arrangements for the participants’ details. Infor-
mation will be held securely on paper/electronically at the 
University of York. The data (other than consent forms) 
transferred to or from the University of York will be coded 
with a study enrolment number and will not have partic-
ipants’ identifiers. We have studied the conditions under 
which disclosures to law enforcement agencies are required 
and are satisfied that the chances of these occurring (crim-
inal activities) are highly unlikely.
To engage our academic audience and the research 
fraternity, we will publish the results of the study in peer- 
reviewed journals. We will also present our findings at an 
international public health conference and an international 
tobacco control conference. We will also publish an abstract 
of our findings on the websites of all the partner institutions. 
We will also present our work to regional research meet-
ings. Additionally, we will incorporate the learning from 
this project into academic lectures for master’s students of 
public health. We have already established national stake-
holder groups in all three target countries, who will guide 
the study conduct and help us in the dissemination of our 
findings.
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